ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryFinance & InsurancePrivate Equity & Venture CapitalLausanneDebiopharm Innovation Fund SA
Debiopharm Innovation Fund SA Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Debiopharm Innovation Fund SA is a strategic corporate fund that invests in Smart Data and digital health companies developing technologies applicable to oncology or infectious diseases. In addition to financing, the fund provides strategic guidance and access to Debiopharm’s pharmaceutical expertise and network to support startup development.

AI-generated
Offering

Products & services

Industry:Private Equity & Venture Capital
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.2/5

Debiopharm Innovation Fund SA

✓ Offered3
Investments in start-ups
Investments in Pre-Seed, Seed and Series A rounds for start-ups in smart data, digital health and technologies for oncology and infectious diseases.
Strategic support and pharma expertise
Strategic guidance for portfolio companies, access to internal experts, translational medicine, regulatory affairs, clinical development as well as business and commercial know-how.
Access to networks and collaboration
Access to investors, strategic partners, pharmaceutical stakeholders, pilot projects, collaborations and connections with other portfolio companies.
Trust & reputation

ranQ Trust Score of Debiopharm Innovation Fund SA: 4.2 out of 5.0

Trust Score4.2/ 5.0

Very high

x

Data basis 96% · As of October 2026

Debiopharm Innovation Fund SA scores 65.0 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.65.024%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.40.910%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.95.08%
Debiopharm Innovation Fund SA scores 89.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Debiopharm Innovation Fund SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Debiopharm Innovation Fund SA scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Debiopharm Innovation Fund SA reaches a ranQ Trust Score of 4.2 out of 5.0 — rated «Very high». The rating draws, among other things, on 4.3 out of 5 stars from 4 customer reviews. The data basis is 96%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
4.3
of 5

Aggregated from 4 reviews across all connected sources

Sources
GGoogle4.34
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Knowledge

No knowledge articles yet

Once Debiopharm Innovation Fund SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Debiopharm Innovation Fund SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Debiopharm Innovation Fund SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Debiopharm Innovation Fund SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Chemin Messidor 5-7
1006 Lausanne
Opening hours
Mon
08:00 - 18:00
Tue
08:00 - 18:00
Wed
08:00 - 18:00
Thu
08:00 - 18:00
Fri
08:00 - 18:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-112.050.229
Founded
2004 · 22 years
Last commercial register change
June 10, 2025
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    MM
    Midi Management SA
    Lausanne
    AC
    Albisser Consulting SA
    Lausanne
    NV
    Neuw Ventures SA
    Chesières
    WV
    WeBuild Ventures SA
    Morges
    EV
    E4 VC SA
    Lausanne
    HP
    HELVEON Partners SA
    Lausanne
    RM
    Renaissance Management SA
    Lausanne
    TS
    time2market SA
    Ecublens Vd